TELA Bio (TELA) Inventory (2018 - 2026)

TELA Bio's Inventory history runs 9 years deep, the most recent figure standing at $12.2 million for Q1 2026.

• On a quarterly basis, Inventory fell 9.75% year-over-year to $12.2 million in Q1 2026; TTM through Mar 2026 was $12.2 million, a 9.75% decrease from a year earlier, with the FY2025 full-year figure at $11.0 million, down 13.81% from the prior year.
• Inventory advanced to $12.2 million in Q1 2026 per TELA's latest filing, from $11.0 million in the prior quarter.
• Across five years, Inventory topped out at $15.1 million in Q1 2023 and bottomed at $10.3 million in Q1 2022.
• The 5-year median for Inventory is $12.8 million (2024), against an average of $12.6 million.
• Across the five-year window, Inventory soared 128.54% in 2022 and declined 15.01% in 2025, its largest moves.
• Year by year, Inventory stood at $11.8 million in 2022, then gained by 11.62% to $13.2 million in 2023, then dropped by 2.89% to $12.8 million in 2024, then dropped by 13.81% to $11.0 million in 2025, then grew by 10.87% to $12.2 million in 2026.
• Per Business Quant, the three latest TELA Inventory figures stand at $12.2 million (Q1 2026), $11.0 million (Q4 2025), and $11.6 million (Q3 2025).